XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Previously Reported
Preferred Stock
Series A Convertible Preferred Stock
Previously Reported
Preferred Stock
Series A Convertible Preferred Stock
Revision of Prior Period Adjustment
Preferred Stock
Series B Convertible Preferred Stock
Previously Reported
Preferred Stock
Series B Convertible Preferred Stock
Revision of Prior Period Adjustment
Common Stock
Common Class A
Common Stock
Common Class A
Previously Reported
Common Stock
Common Class A
Revision of Prior Period Adjustment
Common Stock
Common Class B
Previously Reported
Common Stock
Common Class B
Revision of Prior Period Adjustment
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Revision of Prior Period Adjustment
Retained Earnings
Retained Earnings
Previously Reported
Noncontrolling Interest
Noncontrolling Interest
Previously Reported
Balance at December 31, 2019 at Dec. 31, 2019 $ 11,473 $ 11,473         $ 8   $ 8 $ 7 $ (7) $ 54,525 $ 54,518 $ 7 $ (43,057) $ (43,057) $ (3) $ (3)
Temporary equity beginning balance (in Shares) at Dec. 31, 2019     5,421,446 (5,421,446) 3,158,338 (3,158,338)                        
Temporary equity beginning balance at Dec. 31, 2019     $ 5 $ (5) $ 3 $ (3)                        
Beginning balance (in Shares) at Dec. 31, 2019             81,756,305 109,536 81,646,769 7,250,001 (7,250,001)              
Vesting of founder shares subject to repurchase 75                     75            
Vesting of founder shares subject to repurchase (in Shares)             3,846,917                      
Issuance of common stock, net of issuance cost 38,647           $ 2         38,645            
Issuance of common stock, net of issuance cost, Shares             18,117,573                      
Issuance of common stock warrants 1,220                     1,220            
Stock-based compensation 2,291                     2,291            
Exercise of stock options $ 124                     124            
Exercise of stock options (in Shares) 318,564           318,559                      
Net loss $ (20,926)                           (20,926)      
Balance at December 31, 2020 at Dec. 31, 2020 32,904           $ 10         96,880     (63,983)   (3)  
Ending balance (in Shares) at Dec. 31, 2020             104,039,354                      
Purchase of non-controlling interest (200)                     (203)         $ 3  
Cashless exercise of common stock warrants (in Shares)             999,185                      
Issuance of common stock upon Merger, net of transaction costs (94)           $ 1         (95)            
Issuance of common stock upon Merger, net of transaction costs (in Shares)             10,525,990                      
Issuance of PIPE shares 220,000           $ 2         219,998            
Issuance of PIPE shares (in Shares)             22,000,000                      
Shares withheld on vesting of restricted stock (284)                     (284)            
Stock-based compensation 43,118                     43,118            
Exercise of stock options $ 26           $ 1         25            
Exercise of stock options (in Shares) 158,129           158,129                      
Net loss $ (81,508)                           (81,508)      
Balance at December 31, 2020 at Dec. 31, 2021 $ 213,962           $ 14         $ 359,439     $ (145,491)      
Ending balance (in Shares) at Dec. 31, 2021             137,722,658